Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C
about
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patientsQuantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activationInfluence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.
P2860
Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Convenient biological assay fo ...... s in patients with hepatitis C
@en
Convenient biological assay fo ...... in patients with hepatitis C.
@nl
type
label
Convenient biological assay fo ...... s in patients with hepatitis C
@en
Convenient biological assay fo ...... in patients with hepatitis C.
@nl
prefLabel
Convenient biological assay fo ...... s in patients with hepatitis C
@en
Convenient biological assay fo ...... in patients with hepatitis C.
@nl
P2093
P2860
P50
P1476
Convenient biological assay fo ...... s in patients with hepatitis C
@en
P2093
Anne Boulestin
Florence Legrand-Abravanel
Jean-Pierre Vinel
Karine Sandres-Saune
Laurent Alric
P2860
P304
P356
10.1128/AAC.48.9.3610-3612.2004
P407
P577
2004-09-01T00:00:00Z